scholarly article | Q13442814 |
P50 | author | Vincenzo Crunelli | Q61978377 |
François David | Q83410831 | ||
Giuseppe Di Giovanni | Q42469477 | ||
P2093 | author name string | Cristiano Bombardi | |
Marcello Venzi | |||
Anna Cavaccini | |||
Joachim Bellet | |||
P2860 | cites work | Cortical control of generalized absence seizures: effect of lidocaine applied to the somatosensory cortex in WAG/Rij rats | Q48882222 |
Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex | Q73280252 | ||
Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents | Q77608922 | ||
FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data | Q21296817 | ||
Functional Selectivity and Classical Concepts of Quantitative Pharmacology | Q22242288 | ||
Hallucinogens | Q22251224 | ||
Identification of a serotonin/glutamate receptor complex implicated in psychosis | Q24655484 | ||
Opportunities for improving animal welfare in rodent models of epilepsy and seizures | Q26786226 | ||
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors | Q27347603 | ||
Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link? | Q28080944 | ||
Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors | Q28119146 | ||
Molecular, pharmacological and functional diversity of 5-HT receptors | Q28206145 | ||
Genetic absence epilepsy in rats from Strasbourg--a review | Q28260153 | ||
1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists | Q28263375 | ||
Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies | Q28293380 | ||
Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine | Q28366550 | ||
Contribution of transient receptor potential channels to the control of GABA release from dendrites | Q28510991 | ||
Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex | Q28567004 | ||
Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat | Q28570127 | ||
The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizures | Q30273949 | ||
5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice | Q30484420 | ||
Enhanced tonic GABAA inhibition in typical absence epilepsy. | Q30493216 | ||
Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement | Q30559794 | ||
The control of seizures by the basal ganglia? A review of experimental data. | Q30757339 | ||
Childhood absence epilepsy: genes, channels, neurons and networks. | Q30835420 | ||
The genetic absence epilepsy rat from Strasbourg as a model to decipher the neuronal and network mechanisms of generalized idiopathic epilepsies | Q30970461 | ||
Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study | Q33864659 | ||
Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding | Q34154263 | ||
Investigating local and long-range neuronal network dynamics by simultaneous optogenetics, reverse microdialysis and silicon probe recordings in vivo | Q34185595 | ||
SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist | Q34432766 | ||
Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. | Q34474361 | ||
Activity Modes in Thalamocortical Relay Neurons are Modulated by G(q)/G(11) Family G-proteins - Serotonergic and Glutamatergic Signaling | Q34508357 | ||
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity | Q34562888 | ||
Dopamine and serotonin receptor binding and antipsychotic efficacy | Q34605995 | ||
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization | Q34746665 | ||
5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential | Q34750267 | ||
Molecular biology of 5-HT receptors | Q34788155 | ||
The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis | Q35007677 | ||
Symptoms of anxiety and depression in childhood absence epilepsy | Q35132044 | ||
Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats | Q35566188 | ||
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy | Q35693028 | ||
Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs | Q36002948 | ||
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex. | Q36126606 | ||
Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats | Q36427038 | ||
Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction | Q36540945 | ||
Sleep and epilepsy: a summary of the 2011 merritt-putnam symposium | Q36623350 | ||
Serotonin and epilepsy | Q36703063 | ||
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile | Q36798643 | ||
Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model | Q37125668 | ||
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies | Q37260873 | ||
Serotonin-dopamine interaction: electrophysiological evidence | Q37260878 | ||
The WAG/Rij strain: A genetic animal model of absence epilepsy with comorbidity of depressiony | Q37811198 | ||
Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation | Q37834732 | ||
From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists | Q38138298 | ||
Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field | Q38150698 | ||
The role of different serotonin receptor subtypes in seizure susceptibility. | Q38162732 | ||
A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures. | Q38268879 | ||
Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex. | Q38299958 | ||
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders | Q38652598 | ||
Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein | Q40367280 | ||
‘Wet-Dog’ shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity☆ | Q40665037 | ||
6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist | Q41081403 | ||
Anticonvulsant compounds and 5-hydroxytryptamine in rat brain | Q42089853 | ||
Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens | Q42175158 | ||
The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. | Q42435261 | ||
Serotonergic projections and serotonin receptor expression in the reticular nucleus of the thalamus in the rat. | Q42483776 | ||
Neuromodulatory role of serotonin in the ferret thalamus | Q42519692 | ||
Activation of 5-HT2A receptors by TCB-2 induces recurrent oscillatory burst discharge in layer 5 pyramidal neurons of the mPFC in vitro | Q42736308 | ||
Serotonergic modulation of absence-like seizures in groggy rats: a novel rat model of absence epilepsy | Q42927017 | ||
Differences in response to serotonergic activation between first and higher order thalamic nuclei | Q43076307 | ||
Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific. | Q43188186 | ||
Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neurones | Q43450968 | ||
A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h). | Q43548350 | ||
Neurotransmission in rats' spontaneous generalized nonconvulsive epilepsy | Q44006385 | ||
Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence | Q44106343 | ||
The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain | Q44247651 | ||
Is spontaneous high-voltage rhythmic spike discharge in Long Evans rats an absence-like seizure activity? | Q44491434 | ||
5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy | Q44760160 | ||
Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. | Q44872295 | ||
The influence of gender on the aggravation of absence seizures by carbamazepine in the low-dose pentylenetetrazol rat model | Q44879166 | ||
Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons | Q44885392 | ||
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion | Q44962619 | ||
Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys | Q45243882 | ||
Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice | Q46069611 | ||
Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles | Q46240693 | ||
Gain modulation by serotonin in pyramidal neurones of the rat prefrontal cortex | Q46477242 | ||
Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalami | Q46788524 | ||
Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current. | Q46842339 | ||
Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation | Q46893789 | ||
The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. | Q46902119 | ||
Serotonin depletion attenuates AY-9944-mediated atypical absence seizures. | Q46962018 | ||
The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics | Q47646787 | ||
Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats | Q47856836 | ||
The effects of systemic administration and local microinjection into the central nervous system of the selective serotonin 5-HT2C receptor agonist RO-600175 on sleep and wakefulness in the rat. | Q47976192 | ||
Unique expression patterns of 5-HT2A and 5-HT2C receptors in the rat brain during postnatal development: Western blot and immunohistochemical analyses | Q48108957 | ||
Deep layer somatosensory cortical neurons initiate spike-and-wave discharges in a genetic model of absence seizures. | Q48136760 | ||
Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis | Q48313604 | ||
Pathophysiological mechanisms of genetic absence epilepsy in the rat. | Q48461890 | ||
Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development | Q48477424 | ||
Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement | Q48655865 | ||
P304 | page(s) | 292-304 | |
P577 | publication date | 2016-04-13 | |
P1433 | published in | Neuropharmacology | Q15332439 |
P1476 | title | Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures | |
P478 | volume | 108 |
Q39164871 | A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment |
Q90395863 | Acute and Chronic Nicotine Exposures Differentially Affect Central Serotonin 2A Receptor Function: Focus on the Lateral Habenula |
Q57468371 | Current Treatment Strategies and Future Treatment Options for Dravet Syndrome |
Q97883048 | Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain |
Q58694358 | Lorcaserin therapy for severe epilepsy of childhood onset: A case series |
Q48026143 | Modulating the Serotonin Receptor Spectrum of Pulicatin Natural Products |
Q28074736 | Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs |
Q56352717 | Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence |
Q61946884 | Suppression of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Function in Thalamocortical Neurons Prevents Genetically Determined and Pharmacologically Induced Absence Seizures |
Q92176310 | Trazodone increases seizures in a genetic WAG/Rij rat model of absence epilepsy while decreasing them in penicillin-evoked focal seizure model |
Q42577060 | Updating neuropathology and neuropharmacology of monoaminergic systems |
Search more.